These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 18537080)

  • 1. Progesterone is extensively metabolized in osteoblasts: implications for progesterone action on bone.
    Quinkler M; Kaur K; Hewison M; Stewart PM; Cooper MS
    Horm Metab Res; 2008 Oct; 40(10):679-84. PubMed ID: 18537080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone regulation of cFos mRNA in osteoprogenitors.
    Shur I; Socher R; Benayahu D
    J Cell Physiol; 2005 Jan; 202(1):240-5. PubMed ID: 15389524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of TAK-778 on gene expression of osteoblastic cells is mediated through estrogen receptor.
    Bellesini LS; Beloti MM; Crippa GE; Bombonato-Prado KF; Junta CM; Marques MM; Passos GA; Rosa AL
    Exp Biol Med (Maywood); 2009 Feb; 234(2):190-9. PubMed ID: 19064943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioconversion of norethisterone, a progesterone receptor agonist into estrogen receptor agonists in osteoblastic cells.
    Lemus AE; Enríquez J; Hernández A; Santillán R; Pérez-Palacios G
    J Endocrinol; 2009 Feb; 200(2):199-206. PubMed ID: 19008332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
    Smuc T; Rizner TL
    Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of the effects of genistein, estradiol and raloxifene on the murine skeletal system.
    Sliwiński L; Folwarczna J; Nowińska B; Cegieła U; Pytlik M; Kaczmarczyk-Sedlak I; Trzeciak H; Trzeciak HI
    Acta Biochim Pol; 2009; 56(2):261-70. PubMed ID: 19401787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCL20/CCR6 chemokine/receptor expression in bone tissue from osteoarthritis and rheumatoid arthritis patients: different response of osteoblasts in the two groups.
    Lisignoli G; Manferdini C; Codeluppi K; Piacentini A; Grassi F; Cattini L; Filardo G; Facchini A
    J Cell Physiol; 2009 Oct; 221(1):154-60. PubMed ID: 19492413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for multiple peroxisome proliferator-activated receptor gamma transcripts in bone: fine-tuning by hormonal regulation and mRNA stability.
    Bruedigam C; Koedam M; Chiba H; Eijken M; van Leeuwen JP
    FEBS Lett; 2008 May; 582(11):1618-24. PubMed ID: 18435931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer.
    Smuc T; Rizner TL
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):74-82. PubMed ID: 18930784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17beta-Estradiol overcomes human myeloma RPMI8226 cell suppression of growth, ALP activity, and mineralization in rat osteoblasts and improves RANKL/OPG balance in vitro.
    Li Q; Yu K; Tian X; Kong F; You Y; Chen Z; Zou P
    Leuk Res; 2009 Sep; 33(9):1266-71. PubMed ID: 19167063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-aromatase effect of progesterone and of its natural metabolites 20alpha- and 5alpha-dihydroprogesterone in the MCF-7aro breast cancer cell line.
    Pasqualini JR; Chetrite G
    Anticancer Res; 2008; 28(4B):2129-33. PubMed ID: 18751385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells.
    Nagata A; Tanaka T; Minezawa A; Poyurovsky M; Mayama T; Suzuki S; Hashimoto N; Yoshida T; Suyama K; Miyata A; Hosokawa H; Nakayama T; Tatsuno I
    J Cell Physiol; 2009 Oct; 221(1):75-83. PubMed ID: 19496170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone enhances basal and TNF-alpha-stimulated production of PAI-1 via the glucocorticoid receptor regardless of 11beta-hydroxysteroid dehydrogenase 2 status in human proximal renal tubular cells.
    Kimura H; Li X; Torii K; Okada T; Kamiyama K; Mikami D; Takahashi N; Yoshida H
    Nephrol Dial Transplant; 2009 Jun; 24(6):1759-65. PubMed ID: 19153071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of fetal osteoblasts and formation of mineralized bone nodules by 45S5 Bioglass conditioned medium in the absence of osteogenic supplements.
    Tsigkou O; Jones JR; Polak JM; Stevens MM
    Biomaterials; 2009 Jul; 30(21):3542-50. PubMed ID: 19339047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AKR1C1 and SRD5A1 messenger RNA expression at term in the human myometrium and chorioamniotic membranes.
    Lee RH; Stanczyk FZ; Stolz A; Ji Q; Yang G; Goodwin TM
    Am J Perinatol; 2008 Oct; 25(9):577-82. PubMed ID: 18770491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone metabolism in adipose cells.
    Zhang Y; Nadeau M; Faucher F; Lescelleur O; Biron S; Daris M; Rhéaume C; Luu-The V; Tchernof A
    Mol Cell Endocrinol; 2009 Jan; 298(1-2):76-83. PubMed ID: 18984031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells.
    Nakao Y; Koike T; Ohta Y; Manaka T; Imai Y; Takaoka K
    Bone; 2009 May; 44(5):872-7. PubMed ID: 19442611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation-dependent progesterone synthesis and metabolism in NT2-N human neurons.
    Pistritto G; Papacleovoulou G; Ragone G; Di Cesare S; Papaleo V; Mason JI; Barbaccia ML
    Exp Neurol; 2009 Jun; 217(2):302-11. PubMed ID: 19306873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calmodulin-dependent kinase 1beta is expressed in the epiphyseal growth plate and regulates proliferation of mouse calvarial osteoblasts in vitro.
    Pedersen ME; Fortunati D; Nielsen M; Brorson SH; Lekva T; Nissen-Meyer LS; Gautvik VT; Shahdadfar A; Gautvik KM; Jemtland R
    Bone; 2008 Oct; 43(4):700-7. PubMed ID: 18620088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone loss induced by Runx2 over-expression in mice is blunted by osteoblastic over-expression of TIMP-1.
    Schiltz C; Prouillet C; Marty C; Merciris D; Collet C; de Vernejoul MC; Geoffroy V
    J Cell Physiol; 2010 Jan; 222(1):219-29. PubMed ID: 19780057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.